Search
for

    Research 10 of 68

    1. Discoid lupus erythematosus successfully treated with deucravacitinib JAAD Case Reports · 2024 · 13 citations
    2. Treatment of discoid lupus erythematosus scarring alopecia with deucravacitinib: A case report SAGE Open Medical Case Reports · 2025 · 3 citations
    3. Complete hair regrowth in a patient with severe alopecia areata treated with deucravacitinib Clinical and Experimental Dermatology · 2025 · 1 citations
    4. Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report SAGE open medical case reports · 2023 · 1 citations
    5. Deucravacitinib in dermatology: current indication and existing off-label data Drugs in Context · 2026
    6. TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris 2026
    7. Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial British Journal of Dermatology · 2026
    8. Review of Promising Off-Label Use of Deucravacitinib International Journal of Molecular Sciences · 2025
    9. Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2025
    10. Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2024
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →